# Hospital Regimens Including Probiotics Guide the Individual Development of the Gut Microbiome of Very Low Birth Weight Infants in the First Two Weeks of Life.

- **DOI:** [10.3390/nu12051256](https://doi.org/10.3390/nu12051256)
- **Rating:** Limited (2.5 out of 5)
- **Verdict:** Longitudinal profiling maps early gut microbiome differences across three neonatal units, but center-level confounding prevents attribution to probiotic or antibiotic regimens.
- **Framework version:** v5.13
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-11-13
- **Evaluation page:** https://www.nabu.science/paper/10.3390%2Fnu12051256

## Key claims

1. We found that hospital regimens significantly influenced the microbiome composition, diversity and quantity right from the beginning and all the way up to the more mature microbiome starting from two to three weeks of age onwards.
   - Support: Tentative
   - Type: Primary finding
   - Basis: center, nutrition and regimen differences are inseparable in the three-center observational comparison
   - Location: Section 5, Conclusions
2. Probiotics were found to initiate an earlier increase of bacterial load, and this in turn might play a role in the prevention of neonatal morbidities.
   - Support: Tentative
   - Type: Secondary
   - Basis: confounded center comparisons cannot identify probiotic effects, and earlier load increase occurred only in Center G
   - Location: Section 5, Conclusions
3. The use of an oral antibiotic for prophylaxis of NEC was found to not be associated with a reduced diversity or reduced abundance of microbiome signatures (disproval of hypothesis 2).
   - Support: Tentative
   - Type: Secondary
   - Basis: concurrent feeding and drug-regimen differences prevent the center comparison from excluding adverse antibiotic effects
   - Location: Section 4, Discussion
4. Probiotics proved to be safe
   - Support: Tentative
   - Type: Secondary
   - Basis: the small survivor-only cohort and absence of systematically analyzed safety endpoints cannot establish safety
   - Location: Abstract, Conclusion
5. Notably, certain infants from centers G (5/18) and K (5/18) did not show any response to probiotic treatment, with restricted colonization by Lactobacillus, as compared to the other infants in the same study group (“high responders”).
   - Support: Supported
   - Type: Secondary
   - Basis: individual longitudinal profiles document restricted Lactobacillus abundance within both probiotic centers
   - Location: Section 3, Results

## Strengths

- **Serial sampling captures early microbial development** Every-other-day stool sampling in 54 very low birth weight infants provides longitudinal observations spanning meconium and the first two weeks of life.
  - Dimension: methodological rigour
  - Location: Methods 2.1; Results
- **Individual profiles reveal variable probiotic response** The Results identify restricted Lactobacillus abundance in 5 of 18 infants in each probiotic center, documenting heterogeneity obscured by center averages.
  - Dimension: contribution
  - Location: Results, individual probiotic-response paragraph
- **Discussion examines alternative microbial signal explanations** The Discussion considers primer bias in probiotic-genus abundance and possible environmental or formula-related sources of Geobacillus, connecting the observations to relevant literature.
  - Dimension: positioning
  - Location: Discussion, primer-bias and Geobacillus paragraphs

## Limitations

- **Center differences prevent treatment effect attribution** Probiotic, antibiotic, antifungal and feeding practices vary together across the three NICUs. The causal regimen conclusions and assertion of proven probiotic safety exceed what this comparison can establish.
  - Dimension: methodological rigour
  - Location: Methods 2.1; Abstract, Conclusion; Conclusions
- **General probiotic conclusion contradicts center findings** The Abstract and Conclusions attribute earlier bacterial-load increase to probiotics, but Results identifies the earlier increase only in Center G. The Discussion explicitly states that probiotic-only Center K did not show faster increases.
  - Dimension: methodological rigour
  - Location: Abstract, Results and Conclusion; Results, qPCR paragraph; Discussion, quantitative PCR paragraph
- **Longitudinal dependence and survivor selection remain unaddressed** Sample-wise comparisons use 383 observations from 54 infants without reported infant-level blocking or a repeated-measures model. Requiring three-week survival also restricts safety and NEC interpretations to survivors.
  - Dimension: methodological rigour
  - Location: Methods 2.1–2.2; Results, sample counts and diversity analyses

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted
  - Probiotics were found to initiate an earlier increase of bacterial load: "The bacterial load was found to increase earlier on when probiotics were used." (Abstract (Results)) vs "the presence of probiotics in absence of antibiotics did not result in faster increases of bacterial load" (Discussion, paragraph on quantitative PCR data). Compare the general probiotic claim with the center-specific account: earlier increase occurred in Center G but not in the other probiotic center, K. → Not supported by the paper's own data
  - Meconium was not found to be free from bacterial DNA: "In total, 17 negative controls were processed and taken into account in subsequent analysis." (Methods 2.2 Microbiome analyses) vs "Overall, 383 samples and 16 negative controls, totaling more than 30 million reads, were processed for analysis." (Results, paragraph 2). Compare the Methods count of 17 negative controls included in analysis with the Results count of 16. → Effect on result unclear
  - Minor reporting notes (1):
    - Descriptive: "No probiotic genera were detected in stool samples when infants did not receive probiotics." (Discussion, paragraph 4) vs "Center L: 0.677% lactobacilli and 0.088% Bifidobacteria" (Results, paragraph on probiotic abundance). Compare the statement of no detection with the nonzero relative abundances reported for the no-probiotic center. → Conclusion holds
- **Reporting and transparency:** Clean. Ethics approval, parental consent, trial registration and an ENA accession are declared. The historical NEC incidence dataset is explicitly attributed separately from the prospective cohort.
  - Ethics approval: declared · Data availability: declared
- **Reference integrity:** Clean. 36 of 37 checkable references verified
  - 39 references in manuscript
  - 2 are books, websites or datasets — counted, but not index-checkable
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-11-13
